276 related articles for article (PubMed ID: 12688511)
1. Pioglitazone, a PPAR-gamma ligand, provides protection from dextran sulfate sodium-induced colitis in mice in association with inhibition of the NF-kappaB-cytokine cascade.
Takagi T; Naito Y; Tomatsuri N; Handa O; Ichikawa H; Yoshida N; Yoshikawa T
Redox Rep; 2002; 7(5):283-9. PubMed ID: 12688511
[TBL] [Abstract][Full Text] [Related]
2. alpha-Phenyl-N-tert-butylnitrone provides protection from dextran sulfate sodium-induced colitis in mice.
Naito Y; Takagi T; Ishikawa T; Handa O; Matsumoto N; Yagi N; Matsuyama K; Yoshida N; Yoshikawa T; Kotake Y
Antioxid Redox Signal; 2002 Feb; 4(1):195-206. PubMed ID: 11970853
[TBL] [Abstract][Full Text] [Related]
3. Reduced intestinal inflammation induced by dextran sodium sulfate in interleukin-6-deficient mice.
Naito Y; Takagi T; Uchiyama K; Kuroda M; Kokura S; Ichikawa H; Yanagisawa R; Inoue K; Takano H; Satoh M; Yoshida N; Okanoue T; Yoshikawa T
Int J Mol Med; 2004 Aug; 14(2):191-6. PubMed ID: 15254764
[TBL] [Abstract][Full Text] [Related]
4. Suppression of intestinal ischemia-reperfusion injury by a specific peroxisome proliferator-activated receptor-gamma ligand, pioglitazone, in rats.
Naito Y; Takagi T; Uchiyama K; Handa O; Tomatsuri N; Imamoto E; Kokura S; Ichikawa H; Yoshida N; Yoshikawa T
Redox Rep; 2002; 7(5):294-9. PubMed ID: 12688513
[TBL] [Abstract][Full Text] [Related]
5. Oroxyloside prevents dextran sulfate sodium-induced experimental colitis in mice by inhibiting NF-κB pathway through PPARγ activation.
Wang X; Sun Y; Zhao Y; Ding Y; Zhang X; Kong L; Li Z; Guo Q; Zhao L
Biochem Pharmacol; 2016 Apr; 106():70-81. PubMed ID: 26947454
[TBL] [Abstract][Full Text] [Related]
6. Rosuvastatin, a new HMG-CoA reductase inhibitor, reduces the colonic inflammatory response in dextran sulfate sodium-induced colitis in mice.
Naito Y; Katada K; Takagi T; Tsuboi H; Isozaki Y; Handa O; Kokura S; Yoshida N; Ichikawa H; Yoshikawa T
Int J Mol Med; 2006 Jun; 17(6):997-1004. PubMed ID: 16685407
[TBL] [Abstract][Full Text] [Related]
7. Enhanced intestinal inflammation induced by dextran sulfate sodium in tumor necrosis factor-alpha deficient mice.
Naito Y; Takagi T; Handa O; Ishikawa T; Nakagawa S; Yamaguchi T; Yoshida N; Minami M; Kita M; Imanishi J; Yoshikawa T
J Gastroenterol Hepatol; 2003 May; 18(5):560-9. PubMed ID: 12702049
[TBL] [Abstract][Full Text] [Related]
8. A specific peroxisome proliferator-activated receptor-gamma (PPAR-gamma) ligand, pioglitazone, ameliorates gastric mucosal damage induced by ischemia and reperfusion in rats.
Ichikawa H; Naito Y; Takagi T; Tomatsuri N; Yoshida N; Yoshikawa T
Redox Rep; 2002; 7(5):343-6. PubMed ID: 12688526
[TBL] [Abstract][Full Text] [Related]
9. Involvement of nitric oxide with activation of Toll-like receptor 4 signaling in mice with dextran sodium sulfate-induced colitis.
Tun X; Yasukawa K; Yamada K
Free Radic Biol Med; 2014 Sep; 74():108-17. PubMed ID: 24992835
[TBL] [Abstract][Full Text] [Related]
10. The inducible nitric oxide synthase inhibitor ONO-1714 blunts dextran sulfate sodium colitis in mice.
Naito Y; Takagi T; Ishikawa T; Handa O; Matsumoto N; Yagi N; Matsuyama K; Yoshida N; Yoshikawa T
Eur J Pharmacol; 2001 Jan; 412(1):91-9. PubMed ID: 11166740
[TBL] [Abstract][Full Text] [Related]
11. Protection from experimental colitis by theaflavin-3,3'-digallate correlates with inhibition of IKK and NF-kappaB activation.
Ukil A; Maity S; Das PK
Br J Pharmacol; 2006 Sep; 149(1):121-31. PubMed ID: 16880762
[TBL] [Abstract][Full Text] [Related]
12. Protective effects of preischemic treatment with pioglitazone, a peroxisome proliferator-activated receptor-gamma ligand, on lung ischemia-reperfusion injury in rats.
Ito K; Shimada J; Kato D; Toda S; Takagi T; Naito Y; Yoshikawa T; Kitamura N
Eur J Cardiothorac Surg; 2004 Apr; 25(4):530-6. PubMed ID: 15037267
[TBL] [Abstract][Full Text] [Related]
13. Gallic acid suppresses inflammation in dextran sodium sulfate-induced colitis in mice: Possible mechanisms.
Pandurangan AK; Mohebali N; Esa NM; Looi CY; Ismail S; Saadatdoust Z
Int Immunopharmacol; 2015 Oct; 28(2):1034-43. PubMed ID: 26319951
[TBL] [Abstract][Full Text] [Related]
14. Expression of peroxisome proliferator-activated receptor-gamma in macrophage suppresses experimentally induced colitis.
Shah YM; Morimura K; Gonzalez FJ
Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G657-66. PubMed ID: 17095756
[TBL] [Abstract][Full Text] [Related]
15. Partially hydrolyzed guar gum down-regulates colonic inflammatory response in dextran sulfate sodium-induced colitis in mice.
Naito Y; Takagi T; Katada K; Uchiyama K; Kuroda M; Kokura S; Ichikawa H; Watabe J; Yoshida N; Okanoue T; Yoshikawa T
J Nutr Biochem; 2006 Jun; 17(6):402-9. PubMed ID: 16214331
[TBL] [Abstract][Full Text] [Related]
16. Ligands for peroxisome proliferator-activated receptors alpha and gamma inhibit chemically induced colitis and formation of aberrant crypt foci in rats.
Tanaka T; Kohno H; Yoshitani S; Takashima S; Okumura A; Murakami A; Hosokawa M
Cancer Res; 2001 Mar; 61(6):2424-8. PubMed ID: 11289109
[TBL] [Abstract][Full Text] [Related]
17. Effects of peroxisome proliferator-activated receptors-gamma ligands on dextran sodium sulphate-induced colitis in rats.
Celinski K; Dworzanski T; Korolczuk A; Piasecki R; Slomka M; Madro A; Fornal R
J Physiol Pharmacol; 2011 Jun; 62(3):347-56. PubMed ID: 21893696
[TBL] [Abstract][Full Text] [Related]
18. A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response.
Su CG; Wen X; Bailey ST; Jiang W; Rangwala SM; Keilbaugh SA; Flanigan A; Murthy S; Lazar MA; Wu GD
J Clin Invest; 1999 Aug; 104(4):383-9. PubMed ID: 10449430
[TBL] [Abstract][Full Text] [Related]
19. Pioglitazone, a specific PPAR-gamma ligand, inhibits aspirin-induced gastric mucosal injury in rats.
Naito Y; Takagi T; Matsuyama K; Yoshida N; Yoshikawa T
Aliment Pharmacol Ther; 2001 Jun; 15(6):865-73. PubMed ID: 11380325
[TBL] [Abstract][Full Text] [Related]
20. An orally active matrix metalloproteinase inhibitor, ONO-4817, reduces dextran sulfate sodium-induced colitis in mice.
Naito Y; Takagi T; Kuroda M; Katada K; Ichikawa H; Kokura S; Yoshida N; Okanoue T; Yoshikawa T
Inflamm Res; 2004 Sep; 53(9):462-8. PubMed ID: 15550999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
